Myelosuppressive effects of 111indium-pentetreotide therapy for somatostatin receptor expressing neoplasms.

被引：0
|
作者：
Anthony, LB
Woltering, EA
Espenan, GD
Cronin, MD
Maloney, TJ
McCarthy, KE
机构：
[1] Louisiana State Univ, Med Ctr, New Orleans, LA USA
[2] Isotex Inc, Friendswood, TX USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3999
引用
收藏
页码：233B / 233B
页数：1
相关论文
共 50 条
  • [21] Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake
    E. Garin
    A. Devillers
    J. Le Cloirec
    A. M. Bernard
    J. Lescouarc’h
    J. Y. Herry
    J. C. Reubi
    P. Bourguet
    European Journal of Nuclear Medicine, 1998, 25 : 687 - 694
  • [22] Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake
    Garin, E
    Devillers, A
    Le Cloirec, J
    Lescouarc'h, J
    Herry, JY
    Reubi, JC
    Bourguet, P
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (07) : 687 - 694
  • [23] In-111-pentetreotide uptake in accessory spleen: A potential pitfall in somatostatin receptor scintigraphy
    Salihoglu, Yavuz Sami
    Elri, Tarik
    Erdemir, Rabiye Uslu
    Yazgan, Omer
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2016, 31 (02): : 161 - U1162
  • [24] Somatostatin Receptor Subtype Expression and Indium-111Pentetreotide Scintigraphy: New Prognostic Factors for Well-Differentiated Neuroendocrine Gastrointestinal Tumors
    O'Connor, J.
    Belli, S.
    Zamora, V
    Bestani, C.
    Parma, P.
    Dioca, M.
    Cabanne, A.
    Domenichini, E.
    Mendez, G.
    Marmisolle, F.
    Giacomi, N.
    Roca, E.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 127 - 127
  • [25] Optimization of somatostatin receptor imaging with In-111 pentetreotide scintigraphy: a phantom study & clinical imaging
    Kamiya, Takashi
    Fujino, Kouichi
    Ikuta, Rie
    Ogushi, Gaku
    Isohashi, Kayako
    Matsunaga, Keiko
    Kato, Hiroki
    Tatsumi, Mitsuaki
    Watabe, Tadashi
    Shimosegawa, Eku
    Hatazawa, Jun
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [26] Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors
    Schillaci, O
    Spanu, A
    Scopinaro, F
    Falchi, A
    Corleto, V
    Danieli, R
    Marongiu, P
    Pisu, N
    Madeddu, G
    Delle Fave, G
    Madeddu, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (06) : 1687 - 1695
  • [27] 177Lutetium-DOTA-octreotate therapy in progressive somatostatin receptor-expressing neuroendocrine neoplasms
    Delpassand, E.
    Mohammadali, H.
    Thamake, S.
    Broline, S.
    Ranganathan, D.
    Wagh, N.
    Tworowska, I.
    Delpassand, A.
    Puentes, J.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [28] Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression as new prognostic factors for malignant well-differentiated endocrine tumors
    Asnacios, A
    Rochaix, P
    Courbon, F
    Bauvin, E
    Susini, C
    Schulz, S
    Boneu, A
    Buscail, L
    Guimbaud, R
    REGULATORY PEPTIDES, 2004, 122 (01) : 10 - 10
  • [29] Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: New prognostic factors for malignant well-differentiated endocrine tumors
    Asnacios, Amani
    Courbon, Frederic
    Rochaix, Philippe
    Bauvin, Eric
    Cances-Lauwers, Valerie
    Susini, Christiane
    Schulz, Stefan
    Boneu, Andree
    Guimbaud, Rosine
    Buscail, Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 963 - 970
  • [30] Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2:: Molecular imaging after systemic delivery using 111In-Pentetreotide
    McCart, JA
    Mehta, N
    Scollard, D
    Reilly, RM
    Carrasquillo, JA
    Tang, N
    Deng, H
    Miller, M
    Xu, H
    Libutti, SK
    Alexander, HR
    Bartlett, DL
    MOLECULAR THERAPY, 2004, 10 (03) : 553 - 561
12345